--- schema_version: "secwatch.filing_event.v1" accession: "0001193125-26-280337" form_type: "8-K" ticker: "CNTA" cik: "0001847903" company_name: "Centessa Pharmaceuticals plc" filed_at: "2026-06-24T12:56:30+00:00" generated_at: "2026-06-24T13:00:23.216113+00:00" event_type: "m_and_a" sentiment: "neutral" materiality_score: 1.0 calibrated_materiality_score: 1.0 confidence: "high" source: SEC EDGAR --- # Centessa acquired by Eli Lilly for $38/sh plus up to $9/sh CVR ## Summary - Acquisition closed June 24, 2026; Centessa became wholly owned subsidiary of Lilly. - Shareholders received $38.00 cash per share plus one CVR worth up to $9.00 on milestones. - All outstanding equity awards cashed out based on $38.00 consideration; CVRs issued. - Centessa terminated its Oxford Finance loan facility and Leerink ATM sales agreement. - CEO, board, and other officers resigned; Christopher Stokes and Kristina Wright appointed directors. ## SEC filing metadata - accession: 0001193125-26-280337 - form_type: 8-K - ticker: CNTA - cik: 0001847903 - company_name: Centessa Pharmaceuticals plc - filed_at: 2026-06-24T12:56:30+00:00 - event_type: m_and_a - sentiment: neutral - materiality_score: 1.0 - calibrated_materiality_score: 1.0 - confidence: high - sec_items: 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 8.01, 9.01 - EDGAR index: https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/d150381d8k.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001193125-26-280337 - JSON: https://secwatch.observer/filing/0001193125-26-280337.json - Plain text: https://secwatch.observer/filing/0001193125-26-280337.txt ## Key facts - Executive change Samarth Kulkarni departed as Director at Centessa Pharmaceuticals plc. - Action: ceased serving - Role: Director source text: each of Francesco De Rubertis, Mario Alberto Accardi, Arjun Goyal, Mary Lynne Hedley, Mathias Hukkelhoven, Samarth Kulkarni, Carol Stuckley and Brett Zbar ceased serving as a member of the board of directors of Centessa evidence_url: https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm - Executive change Mary Lynne Hedley departed as Director at Centessa Pharmaceuticals plc. - Action: ceased serving - Role: Director source text: each of Francesco De Rubertis, Mario Alberto Accardi, Arjun Goyal, Mary Lynne Hedley, Mathias Hukkelhoven, Samarth Kulkarni, Carol Stuckley and Brett Zbar ceased serving as a member of the board of directors of Centessa evidence_url: https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm - Executive change Raphael Deferiere departed as Executive Officer at Centessa Pharmaceuticals plc. - Action: ceased to serve - Role: Executive Officer source text: Mario Alberto Accardi, Ph.D. (Chief Executive Officer and Director), John Crowley, Stephen Kanes, M.D., Ph.D., and Raphael Deferiere ceased to serve in their capacities as executive officers of Centessa. evidence_url: https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm - Executive change Christopher Stokes was appointed as Director at Centessa Pharmaceuticals plc. - Action: appointed - Role: Director source text: Christopher Stokes and Kristina Mignon Wright were appointed as directors of the Company. evidence_url: https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm - Executive change Mathias Hukkelhoven departed as Director at Centessa Pharmaceuticals plc. - Action: ceased serving - Role: Director source text: each of Francesco De Rubertis, Mario Alberto Accardi, Arjun Goyal, Mary Lynne Hedley, Mathias Hukkelhoven, Samarth Kulkarni, Carol Stuckley and Brett Zbar ceased serving as a member of the board of directors of Centessa evidence_url: https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm - Executive change John Crowley departed as Executive Officer at Centessa Pharmaceuticals plc. - Action: ceased to serve - Role: Executive Officer source text: Mario Alberto Accardi, Ph.D. (Chief Executive Officer and Director), John Crowley, Stephen Kanes, M.D., Ph.D., and Raphael Deferiere ceased to serve in their capacities as executive officers of Centessa. evidence_url: https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm - Executive change Mario Alberto Accardi departed as Chief Executive Officer and Director at Centessa Pharmaceuticals plc. - Action: ceased to serve - Role: Chief Executive Officer and Director source text: Mario Alberto Accardi, Ph.D. (Chief Executive Officer and Director), John Crowley, Stephen Kanes, M.D., Ph.D., and Raphael Deferiere ceased to serve in their capacities as executive officers of Centessa. evidence_url: https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm - Executive change Francesco De Rubertis departed as Director at Centessa Pharmaceuticals plc. - Action: ceased serving - Role: Director source text: each of Francesco De Rubertis, Mario Alberto Accardi, Arjun Goyal, Mary Lynne Hedley, Mathias Hukkelhoven, Samarth Kulkarni, Carol Stuckley and Brett Zbar ceased serving as a member of the board of directors of Centessa evidence_url: https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm - Executive change Stephen Kanes departed as Executive Officer at Centessa Pharmaceuticals plc. - Action: ceased to serve - Role: Executive Officer source text: Mario Alberto Accardi, Ph.D. (Chief Executive Officer and Director), John Crowley, Stephen Kanes, M.D., Ph.D., and Raphael Deferiere ceased to serve in their capacities as executive officers of Centessa. evidence_url: https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm - Executive change Arjun Goyal departed as Director at Centessa Pharmaceuticals plc. - Action: ceased serving - Role: Director source text: each of Francesco De Rubertis, Mario Alberto Accardi, Arjun Goyal, Mary Lynne Hedley, Mathias Hukkelhoven, Samarth Kulkarni, Carol Stuckley and Brett Zbar ceased serving as a member of the board of directors of Centessa evidence_url: https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm - Executive change Brett Zbar departed as Director at Centessa Pharmaceuticals plc. - Action: ceased serving - Role: Director source text: each of Francesco De Rubertis, Mario Alberto Accardi, Arjun Goyal, Mary Lynne Hedley, Mathias Hukkelhoven, Samarth Kulkarni, Carol Stuckley and Brett Zbar ceased serving as a member of the board of directors of Centessa evidence_url: https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm - Executive change Kristina Mignon Wright was appointed as Director at Centessa Pharmaceuticals plc. - Action: appointed - Role: Director source text: Christopher Stokes and Kristina Mignon Wright were appointed as directors of the Company. evidence_url: https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm - Executive change Carol Stuckley departed as Director at Centessa Pharmaceuticals plc. - Action: ceased serving - Role: Director source text: each of Francesco De Rubertis, Mario Alberto Accardi, Arjun Goyal, Mary Lynne Hedley, Mathias Hukkelhoven, Samarth Kulkarni, Carol Stuckley and Brett Zbar ceased serving as a member of the board of directors of Centessa evidence_url: https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.